"It isn't about blame. It is about the company creating

New Post Public Reply Private Reply Replies (1) Message Board
homerbedloe docj #8725
288
"It isn't about blame. It is about the company creating shareholder value. It is about credibility and accountability. I make investments based on information the company provides. I rely on accurate and timely information."

Doc, while I respect your perspective, I wholeheartedly disagree with it. The company has done everything imaginable to create shareholder value - from dividends, to share retirements (that were ignored), to splitting off assets into a separate company which the shareholders will partially own, to announcing LOIs to purchase multiple companies. It has spent stock valued at $2.50/share to make a number of these purchases, while the stock currently trades less than $1. It has gotten major stock holders to forego receiving dividends to prevent unreasonable dilution. I have been around stocks for over 40 years and I have never seen these types of attempts to provide value to shareholders. If you have, please share that with the board, because I don't believe it exists but would be glad to reevaluate my position.

Yes, there have been setbacks with Veneto and Kiromic. Veneto is going to be settled in court as to whether they were honest with GNBT; Kiromic thinks they have a better path without GNBT and are pursuing that path. Everything else is still in play. You are reacting like all these transactions should have already taken place and should be represented in the share price; my take is you have overlooked two things. First, none of these transactions are easy meaning they don't immediately happen. I'm not sure 6 to 9 months is a fair time period to expect the co-mingling of all of the companies with all kinks ironed out. I personally am allowing around 2 years (now down to 1.5) - your mileage obviously varies.

Second, and this is probably the most important, you continue to ignore that we are on the OTC. I've said this before and I guess I will say it again - the pps of most OTC companies does not reflect the actual value or potential of those companies. To use the cliche', it is the wild west and anything goes pps wise.

Right now, some entity(ies) have decided to push the pps down. Why? Accumulation? Short covering? An attempt to bankrupt GNBT/Joe Moscato? I sure don't know, and I doubt anyone (even the all seeing Namtae) does either - with the exception of the entity(ies) that are doing this. But I have bet real money that it is artificial, and if/when we can get to the NAS, I believe much of this will end. The NAS values stocks based on potential and current value, and GNBT certainly has potential right now that isn't being acknowledged on OTC.

The support I offer for this is the fact that OTC did not recognize the share retirement - if they can just ignore a $50 million change in market cap, they are capable of ignoring all sorts of shenanigans regarding the pps. Hell, they may even be complicit with the entity(ies) because they KNOW GNBT is going to move away as soon as the NAS says "c'mon down". The longer they prevent that, the longer they retain GNBT's fees and trades.

I'm not going to try any harder to convince you my position is better than yours. If you truly believe GNBT 2.0 is in reality still GNBT 1.0, there is nothing I can say right now to convince you of anything different because my theory is based on what I believe will occur in the future. I'm sorry you feel that way, and I truly hope you're wrong. I still believe time will tell - we had a month set back with the delayed 10k, so my original prediction of waiting until Thanksgiving is now waiting until shortly after the first of the year. I'm betting real money that we remain on the right track, we're just moving under a temporary slow order (that's a railroad term in my wheel house!). But we're still moving, and I believe we will eventually get there.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 2

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EmpowHer Grants Propel Female-led Social Ventures Forward

Updated Category News Views 4

Every now and then, you stumble upon a story that makes you take off your trading hat and put on your 'citizen of the world' one. The Boundless Futures Foundation is doing just that, pushing past the $1.5 million mark in grant funding to back female founders creating real scale impact. If this doesn't sound like a nonprofit turning the gears of change, I don't know what...

Continue Reading
WareSpace Expands Reach With $36.5M Acquisitions

Updated Category News Views 0

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 0

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Andover Audio's FreePlay: Stereo Sound Goes Portable

Updated Category News Views 5

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Continue Reading
Trust vs. AI: Shapira's Fight in Modern Speechcraft

Updated Category News Views 3

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Continue Reading
AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Updated Category News Views 2

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Continue Reading
Bud Ecosystem Debuts AIOS, Aims to Slash Costs

Updated Category News Views 6

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 2

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading

Top 5 Most Recently Viewed Articles

Ardmore Shipping Prepares for 2026 Investor Day in NYC

Updated Category News Views 112

Ardmore Shipping's 2026 Investor Day Announcement Ardmore Shipping Corporation (NYSE: ASC) has exciting news! The company will host its 2026 Investor Day on February 12, a popular date for many investors and analysts alike. This special event promises to be a deep dive into Ardmore's strategic vision and market positioning. Key Highlights of the Investor Day The Investor...

Continue Reading
Revolutionizing Kitchen Storage with Zephyr's New Drawers

Updated Category News Views 166

Zephyr Enhances Kitchen Versatility with New Drawers Zephyr has made a significant leap in kitchen design and functionality with the introduction of the Presrv™ Refrigerator Freezer Drawers. This innovative addition marks a milestone in home kitchen storage technology, offering a dual-zone system that brilliantly adapts to various storage needs. Unmatched Flexibility...

Continue Reading
Injectable Drug Delivery Market to Exceed $1 Trillion by 2030

Updated Category News Views 230

Global Injectable Drug Delivery Market Growth Overview The global injectable drug delivery market is on a remarkable trajectory, poised to reach an estimated valuation of over US$1,034.78 billion by 2030. With a compound annual growth rate (CAGR) of approximately 8.4%, this market is set to expand significantly driven by various critical factors. Rising Demand and Market...

Continue Reading
QURE Lawsuit Shock: Misled on Gene Therapy Claims?

Updated Category News Views 191

QURE got slapped with a securities fraud class action lawsuit on Feb 18, 2026, stemming from investor accusations about dodgy statements related to its gene therapy for Huntington's disease. The filing rolls back to the Class Period running from September 24, 2025, to October 31, 2025—prime time for share buying before the market learned the real story behind...

Continue Reading
Revolutionizing Robotics: X Square Robot's Major Funding Boost

Updated Category News Views 143

X Square Robot Secures Significant Funding for AI Development X Square Robot, a leading innovator in the realm of embodied AI, has successfully completed its Series A++ funding round, raising approximately $140 million. This funding has attracted renowned investors, including big names in the tech industry, showcasing the company's potential in transforming robotics. The...

Continue Reading